Selected article for: "acute respiratory syndrome and novel coronavirus"

Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
  • Document date: 2020_3_23
  • ID: 9hknw4ws_1
    Snippet: Since December 2019, a novel coronavirus disease (COVID-19) has rapidly spread throughout the world, with outbreaks in more than 200 countries and regions [ 1 , 2 ] . The pathogenic organism responsible was identified and termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously named 2019 novel coronavirus or 2019-nCoV), belonging to the same family of viruses responsible for the severe acute respiratory syndrome (SARS) and.....
    Document: Since December 2019, a novel coronavirus disease (COVID-19) has rapidly spread throughout the world, with outbreaks in more than 200 countries and regions [ 1 , 2 ] . The pathogenic organism responsible was identified and termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously named 2019 novel coronavirus or 2019-nCoV), belonging to the same family of viruses responsible for the severe acute respiratory syndrome (SARS) and

    Search related documents:
    Co phrase search for related documents